GoodRx Holdings Inc. (NASDAQ:GDRX), a leading healthcare technology company specializing in prescription drug discounts and telehealth services, finds itself at a critical juncture. As the company ...

GoodRx is generating solid profitability with growth in monthly active consumers to its prescription drugs discount platform. Management expects stronger trends into the second half of the year. The ...

The company's integrated pharmaceutical platform, accretive growth through disciplined M&A, and undervaluation lead to a 'buy' rating. With a fair value of $6.30, averaged between my DCF and Alpha ...

The stock market is in free fall right now, but it's far worse for shares of prescription-drug discounter GoodRx (NASDAQ: GDRX). The company reported financial results for the first quarter of 2022 ...

Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 1.4% in the afternoon session after the stock's positive momentum continued following a potential partnership with TrumpRx and an expanded ...

Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 3.7% in the afternoon session after investor enthusiasm continued following its recent partnership with Danish pharmaceutical giant Novo ...

You already know the economic recovery from the pandemic is going to be great for travel, dining, and entertainment, but it's also going to be great for a surprising sector: healthcare. As the ...